Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysis
Abstract Background Controversial results still existed on the clinical utility of bone marrow-derived cells (BMCs) for cardiomyopathy (CMP). This study aims to reveal the true power of this promising approach by synthesizing all the available data on this subject matter. Methods Twenty studies incl...
Main Authors: | Chao Wang, Jingzhao Li, Boya Zhang, Yongjian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1238-5 |
Similar Items
-
Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
by: Young Mi Hong, et al.
Published: (2017-11-01) -
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells
by: Arianna Scalco, et al.
Published: (2021-04-01) -
Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
by: Hongwei Tian, et al.
Published: (2018-11-01) -
Hypertrophic Cardiomyopathy in Adolescence
by: Paul F. Kantor, MBBCh, MSc, et al.
Published: (2021-01-01) -
Reversibility of ventricular dysfunction: clinical experience in a medical office
by: Antonio Carlos Pereira Barretto
Published: (2001-12-01)